性健康補充品:全球市場的展望、預測 (2023-2028年)

全球性健康補充品的市場規模，從2022年到2028年預計以8.69％的年複合成長率成長。

電子商務的急速成長，複數劑型的產品的銷售，引起性問題的高風險因素增加，藥草補充品的使用增加等要素預計促進該市場的成長。

本報告提供全球性健康補充品的市場調查，市場定義和概要，市場影響因素及市場機會分析，市場規模的變化、預測，各種區分、各地區的詳細分析，競爭情形，主要企業簡介等彙整資訊。

目錄

第1章 調查手法

第2章 調查目的

第3章 調查流程

第4章 調查範圍

第5章 報告的前提、註記

第6章 重要考察

第7章 市場概要

第8章 簡介

第9章 市場機會、趨勢

第10章 市場成長的實現要素

第11章 阻礙市場要素

第12章 市場形勢

• 市場概要
• 市場規模、預測
  • 各地區的洞察
  • 性別的洞察
  • 各劑型的洞察
  • 各流通管道的洞察
  • 各產品的洞察
• 波特的五力分析

第13章 性別

• 市場概述、成長引擎
• 市場概要
• 男性
• 女性
  • 市場概要
  • 市場規模、預測
  • 各地區市場

第14章 劑型

• 市場概述、成長引擎
• 市場概要
• 膠囊
• 平板電腦
• 軟體凝膠
• 液體
• 粉末
  • 市場概要
  • 市場規模、預測
  • 各地區市場

第15章 流通管道

• 市場概述、成長引擎
• 市場概要
• 離線商店
• 網路商店
  • 市場概要
  • 市場規模、預測
  • 各地區市場

第16章 產品

• 市場概述、成長引擎
• 市場概要
• 天然
• 合成&混合
  • 市場概要
  • 市場規模、預測
  • 各地區市場

第17章 地區

• 市場概述、成長引擎
• 地區概要

第18章 歐洲

第19章 亞太地區

第20章 北美

第21章 南美

第22章 中東、非洲

第23章 競爭情形

第24章 主要企業簡介

• COAST SCIENCE
• LENUS PHARMA GESMBH
• VITABIOTICS
• EXELTIS USA
• FAIRHAVEN HEALTH
• DABUR INDIA LTD.
• HERBALIFE INTERNATIONAL OF AMERICA, INC.

第25章 其他有力供應商

• ADVACARE PHARMA
• BAYER AG
• BELI
• CADI - CAMBRIDGE DIAGNOSTIC IMAGING
• CARLSON LABS
• DCMG LABORATORIES
• ELAN HEALTHCARE
• EU NATURAL
• FULLWELL
• HERA (HERANOW)
• INOVA PHARMACEUTICALS (PTY) LTD.
• LABORATORIOS FERTYPHARM S.L.
• LIFE EXTENSION
• NUTRA BUSINESS
• NUA FERTILITY
• OCEAN HEALTHCARE
• ORTHOMOL
• PURITAN'S PRIDE
• TTK
• THORNE
• AYTU CONSUMER HEALTH INC.
• GNC HOLDINGS, LLC
• HIMALAYA GLOBAL HOLDINGS LTD.
• MAN MATTERS

第26章 報告摘要

• 重要點
• 策略性建議

第27章 定量摘要

第28章 附錄

The global sexual health supplements market is expected to grow at a CAGR of 8.69% from 2022-2028.

MARKET TRENDS & DRIVERS

The Rapid Growth of E-commerce and Product Launches in Multiple Dosage Forms

Over the past years, online pharmacy has grown across the globe. Pharmaceutical vendors offer various sexual health supplements at a discounted price, and customers can validate and verify the medicines being delivered and prescription orders. Players in the sexual health supplements market are launching supplements in multiple dosage forms as per the need for sexual issues and pushing for market expansion. With increasing awareness about improving sexual health and due to the growing e-commerce platform, various sexual health supplements are easily available. Thus, the consumption of sexual health supplements is expected to increase during the forecast period.

Increasing the Number of High-Risk Factors Leading to the Sexual Problems and Increasing the Use of Herbal Supplements

The changing lifestyle of people affects human health with various diseases such as chronic health disease, cancer, diabetes, asthma, mental health issue, and others. All these factors are directly affecting the sexual health of men and women. Due to rising sexual health issues, the need for care also significantly increased. The use of biobased products and herbal supplements is increasing due to increasing the awareness of maintaining health among people. Natural sexual health supplements reduce the risk of side effects, and recently it has been one of the significant factors driving the demand for natural sexual health supplements in the sexual health supplements market.

SEGMENTATION INSIGHTS

INSIGHTS BY GENDER

Sexual health issues are an increasing concern in both men and women. In 2022, the men's segment held the most substantial share of the global sexual health supplements market. Psychology is the major factor that affects both the ability & desire to have sex and mental health. Emotional factor plays a vital role in erectile function. In men, erectile dysfunction is a major sexual disease caused due to various reasons. The reasons include depression, stress, urological surgery, low testosterone, cholesterol, and other diseases. Further, many women also face sexual health issues that are different than men. The awareness about hygiene and health consciousness is very high in women compared to men. Such factors are anticipated to propel the consumption of herbal products in women.

Segmentation by Gender

• Men
• Women

INSIGHTS BY FORMULATION

The global sexual health supplements market by formulation is segmented into capsules, tablets, softgels, liquid, and powder. In 2022, the capsules segment dominated the market, accounting for over 36%. Capsules are used for fast-acting products that easily break down compared to stomach tablets. It promotes bacterial adhesive to interaction with organisms and as a permeability barrier. Moreover, the capsule form of supplements can easily be available in the market and have a high shelf life, and is used in the nutrients industry due to their higher drug absorption property. Capsules are used when the drug cannot be compacted in the solid form. Fairhaven Health, Ocean Healthcare, GNC Holdings, Dabur India, Herbalife, and others are manufacturing sexual health supplements in capsule form. Further, due to their capability of being easy to swallow, the consumption of capsules is increasing in the market.

Segmentation by Formulation

• Capsules
• Tablets
• Softgel
• Liquid
• Powder

INSIGHTS BY DISTRIBUTION CHANNEL

The offline store segment accounted for a high share of the global sexual health supplements market and dominated the market, with a CAGR of 8.03% during the forecast period. Sexual health supplements are available at offline distribution channels such as drug stores, supermarkets, hospital pharmacies, and general stores. In offline stores distribution channels, there are many big players with huge chain pharmacies and many local pharmacy shops in the sexual health supplements market. Further, due to the growing e-commerce platform and online pharmacies, online buyers have increased in the last few years.

Segmentation by Distribution Channel

• Offline Store
• Online Store

INSIGHTS BY PRODUCT

The global sexual health supplements market by product is segmented into natural and synthetic & blends. Both supplements are used to improve sexual health and are available online and offline stores. Synthetic & blend supplements are made of drugs, whereas most natural products contain plants. The high consumption of synthetic & blend sexual health supplements may have adverse side effects on the human body. Thus, natural products are safe due to no use of chemicals and other harmful chemicals in manufacturing. Due to such factors, the natural sexual health supplements segment held a higher market share in 2022. Moreover, the manufacturing cost of natural products is less than synthetic & blended products.

Segmentation by Product

• Natural
• Synthetic & Blend

GEOGRAPHICAL ANALYSIS

Europe is the leading region in the global sexual health supplements market, valued at over USD 727 million in 2022. In Europe, many major players, such as Germany, France, UK, Italy, Spain, and Russia, contribute to the market. The increasing number of diseases is the major cause of rising erectile dysfunction in Europe. Most of the people are well educated in these countries. Thus, they know the importance of maintaining sexual health and following a healthy diet. Further, the people in the region are more aware of natural products; thus, the consumption of sexual health supplements is increasing in European countries.

Segmentation by Geography

• Europe
  • Italy
  • Spain
  • Germany
  • The U.K.
  • France
  • Russia
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
• North America
  • The U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia

VENDOR LANDSCAPE

The global sexual health supplements market is highly fragmented, with many manufacturers across major markets. There are a few major players present in the global sexual health supplements market, such as Coast Science (US), Lenux Pharma GesmbH (Austria), Vitabiotic (UK), Exceltis USA (US), Fairhaven Health (US), Dabur India Ltd. (India), and Herbalife International of America (US). Further, many more players in the market have developed a complete product portfolio for a sexual health supplement.

Key Company Profiles

• Coast Science
• LENUS Pharma GesmbH
• Vitabiotics
• Exeltis USA
• Fairhaven Health
• Dabur India Ltd.
• Herbalife International of America, Inc.

Other Prominent Vendors

• AdvaCare Pharma
• Bayer Ag
• Beli
• CiDi - Cambridge Diagnostic Imaging
• Carlson Labs
• DCMG Laboratories
• Elan Healthcare
• Eu Natural
• FullWell
• Hera
• iNova Pharmaceuticals (Pty) Ltd.
• Laboratories Fertypharm S.L.
• Life Extension
• Nutra Business
• Nua Fertility
• Ocean Healthcare
• Orthomol
• Puritan's Pride
• TTK
• Thorne
• Aytu Consumer Health Inc.
• GNC Holdings, LLC
• Himalaya Global Holdings Ltd.
• Man Matters

KEY QUESTIONS ANSWERED:

• 1. How big is the sexual health supplements market?
• 2. What is the growth rate of the global sexual health supplements market?
• 3. What are the growing trends in the sexual health supplements market?
• 4. Which region holds the most significant global sexual health supplements market share?
• 5. Who are the key vendors in the global sexual health supplements market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

• 4.1 MARKET DEFINITION
  • 4.1.1 INCLUSIONS
  • 4.1.2 EXCLUSIONS
  • 4.1.3 MARKET ESTIMATION CAVEATS
• 4.2 BASE YEAR
• 4.3 SCOPE OF THE STUDY
  • 4.3.1 MARKET SEGMENTATION BY FORMULATION
  • 4.3.2 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
  • 4.3.3 MARKET SEGMENTATION BY PRODUCT
  • 4.3.4 MARKET SEGMENTATION BY GENDER
  • 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

• 5.1 KEY CAVEATS
• 5.2 CURRENCY CONVERSION
• 5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

• 6.1 KEY FINDINGS
• 6.2 MARKET SYNOPSIS

7 MARKET AT A GLANCE

8 INTRODUCTION

• 8.1 SEXUAL HEALTH SUPPLEMENTS
• 8.2 OVERVIEW
  • 8.2.1 OVERVIEW: SEXUAL HEALTH
  • 8.2.2 FACTORS THAT AFFECT SEXUAL HEALTH
  • 8.2.3 SEXUAL HEALTH TREATMENT

9 MARKET OPPORTUNITIES & TRENDS

• 9.1 RAPID GROWTH OF E-COMMERCE
• 9.2 AVAILABILITY OF SUPPLEMENTS IN MULTIPLE DOSAGE FORMS
• 9.3 LAUNCH OF NOVEL SEXUAL HEALTH SUPPLEMENTS

10 MARKET GROWTH ENABLERS

• 10.1 INCREASED HIGH-RISK FACTORS LEADING TO SEXUAL PROBLEMS
• 10.2 HIGH COST & ADVERSE EFFECTS ASSOCIATED WITH DRUGS
• 10.3 INCREASED USE OF HERBAL SUPPLEMENTS

11 MARKET RESTRAINTS

• 11.1 LIMITATIONS & SIDE EFFECTS ASSOCIATED WITH SEXUAL HEALTH SUPPLEMENTS
• 11.2 LACK OF MARKETING & KNOWLEDGE OF PRODUCTS
• 11.3 INTENSE COMPETITION & PRICING PRESSURE

12 MARKET LANDSCAPE

• 12.1 MARKET OVERVIEW
• 12.2 MARKET SIZE & FORECAST
  • 12.2.1 INSIGHT BY GEOGRAPHY
  • 12.2.2 INSIGHT BY GENDER
  • 12.2.3 INSIGHT BY FORMULATION
  • 12.2.4 INSIGHT BY DISTRIBUTION CHANNEL
  • 12.2.5 INSIGHT BY PRODUCT
• 12.3 FIVE FORCES ANALYSIS
  • 12.3.1 THREAT OF NEW ENTRANTS
  • 12.3.2 BARGAINING POWER OF SUPPLIERS
  • 12.3.3 BARGAINING POWER OF BUYERS
  • 12.3.4 THREAT OF SUBSTITUTES
  • 12.3.5 COMPETITIVE RIVALRY

13 GENDER

• 13.1 MARKET SNAPSHOT & GROWTH ENGINE
• 13.2 MARKET OVERVIEW
• 13.3 MEN
  • 13.3.1 MARKET OVERVIEW
  • 13.3.2 MARKET SIZE & FORECAST
  • 13.3.3 MARKET BY GEOGRAPHY
• 13.4 WOMEN
  • 13.4.1 MARKET OVERVIEW
  • 13.4.2 MARKET SIZE & FORECAST
  • 13.4.3 MARKET BY GEOGRAPHY

14 FORMULATION

• 14.1 MARKET SNAPSHOT & GROWTH ENGINE
• 14.2 MARKET OVERVIEW
• 14.3 CAPSULE
  • 14.3.1 MARKET OVERVIEW
  • 14.3.2 MARKET SIZE & FORECAST
  • 14.3.3 MARKET BY GEOGRAPHY
• 14.4 TABLET
  • 14.4.1 MARKET OVERVIEW
  • 14.4.2 MARKET SIZE & FORECAST
  • 14.4.3 MARKET BY GEOGRAPHY
• 14.5 SOFTGEL
  • 14.5.1 MARKET OVERVIEW
  • 14.5.2 MARKET SIZE & FORECAST
  • 14.5.3 MARKET BY GEOGRAPHY
• 14.6 LIQUID
  • 14.6.1 MARKET OVERVIEW
  • 14.6.2 MARKET SIZE & FORECAST
  • 14.6.3 MARKET BY GEOGRAPHY
• 14.7 POWDER
  • 14.7.1 MARKET OVERVIEW
  • 14.7.2 MARKET SIZE & FORECAST
  • 14.7.3 MARKET BY GEOGRAPHY

15 DISTRIBUTION CHANNEL

• 15.1 MARKET SNAPSHOT & GROWTH ENGINE
• 15.2 MARKET OVERVIEW
• 15.3 OFFLINE STORE
  • 15.3.1 MARKET OVERVIEW
  • 15.3.2 MARKET SIZE & FORECAST
  • 15.3.3 MARKET BY GEOGRAPHY
• 15.4 ONLINE STORE
  • 15.4.1 MARKET OVERVIEW
  • 15.4.2 MARKET SIZE & FORECAST
  • 15.4.3 MARKET BY GEOGRAPHY

16 PRODUCT

• 16.1 MARKET SNAPSHOT & GROWTH ENGINE
• 16.2 MARKET OVERVIEW
• 16.3 NATURAL
  • 16.3.1 MARKET OVERVIEW
  • 16.3.2 MARKET SIZE & FORECAST
  • 16.3.3 MARKET BY GEOGRAPHY
• 16.4 SYNTHETIC & BLEND
  • 16.4.1 MARKET OVERVIEW
  • 16.4.2 MARKET SIZE & FORECAST
  • 16.4.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

• 17.1 MARKET SNAPSHOT & GROWTH ENGINE
• 17.2 GEOGRAPHIC OVERVIEW

18 EUROPE

• 18.1 MARKET OVERVIEW
• 18.2 MARKET SIZE & FORECAST
• 18.3 GENDER
  • 18.3.1 MARKET SIZE & FORECAST
• 18.4 FORMULATION
  • 18.4.1 MARKET SIZE & FORECAST
• 18.5 DISTRIBUTION CHANNEL
  • 18.5.1 MARKET SIZE & FORECAST
• 18.6 PRODUCT
  • 18.6.1 MARKET SIZE & FORECAST
• 18.7 KEY COUNTRIES
• 18.8 ITALY
  • 18.8.1 MARKET SIZE & FORECAST
• 18.9 SPAIN
  • 18.9.1 MARKET SIZE & FORECAST
• 18.10 GERMANY
  • 18.10.1 MARKET SIZE & FORECAST
• 18.11 UK
  • 18.11.1 MARKET SIZE & FORECAST
• 18.12 FRANCE
  • 18.12.1 MARKET SIZE & FORECAST
• 18.13 RUSSIA
  • 18.13.1 MARKET SIZE & FORECAST

19 APAC

• 19.1 MARKET OVERVIEW
• 19.2 MARKET SIZE & FORECAST
• 19.3 GENDER
  • 19.3.1 MARKET SIZE & FORECAST
• 19.4 FORMULATION
  • 19.4.1 MARKET SIZE & FORECAST
• 19.5 DISTRIBUTION CHANNEL
  • 19.5.1 MARKET SIZE & FORECAST
• 19.6 PRODUCT
  • 19.6.1 MARKET SIZE & FORECAST
• 19.7 KEY COUNTRIES
• 19.8 CHINA
  • 19.8.1 MARKET SIZE & FORECAST
• 19.9 JAPAN
  • 19.9.1 MARKET SIZE & FORECAST
• 19.10 INDIA
  • 19.10.1 MARKET SIZE & FORECAST
• 19.11 SOUTH KOREA
  • 19.11.1 MARKET SIZE & FORECAST
• 19.12 AUSTRALIA
  • 19.12.1 MARKET SIZE & FORECAST
• 19.13 INDONESIA
  • 19.13.1 MARKET SIZE & FORECAST
• 19.14 THAILAND
  • 19.14.1 MARKET SIZE & FORECAST

20 NORTH AMERICA

• 20.1 MARKET OVERVIEW
• 20.2 MARKET SIZE & FORECAST
• 20.3 GENDER
  • 20.3.1 MARKET SIZE & FORECAST
• 20.4 FORMULATION
  • 20.4.1 MARKET SIZE & FORECAST
• 20.5 DISTRIBUTION CHANNEL
  • 20.5.1 MARKET SIZE & FORECAST
• 20.6 PRODUCT
  • 20.6.1 MARKET SIZE & FORECAST
• 20.7 KEY COUNTRIES
• 20.8 US
  • 20.8.1 MARKET SIZE & FORECAST
• 20.9 CANADA
  • 20.9.1 MARKET SIZE & FORECAST

21 LATIN AMERICA

• 21.1 MARKET OVERVIEW
• 21.2 MARKET SIZE & FORECAST
• 21.3 GENDER
  • 21.3.1 MARKET SIZE & FORECAST
• 21.4 FORMULATION
  • 21.4.1 MARKET SIZE & FORECAST
• 21.5 DISTRIBUTION CHANNEL
  • 21.5.1 MARKET SIZE & FORECAST
• 21.6 PRODUCT
  • 21.6.1 MARKET SIZE & FORECAST
• 21.7 KEY COUNTRIES
• 21.8 BRAZIL
  • 21.8.1 MARKET SIZE & FORECAST
• 21.9 MEXICO
  • 21.9.1 MARKET SIZE & FORECAST
• 21.10 ARGENTINA
  • 21.10.1 MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

• 22.1 MARKET OVERVIEW
• 22.2 MARKET SIZE & FORECAST
• 22.3 GENDER
  • 22.3.1 MARKET SIZE & FORECAST
• 22.4 FORMULATION
  • 22.4.1 MARKET SIZE & FORECAST
• 22.5 DISTRIBUTION CHANNEL
  • 22.5.1 MARKET SIZE & FORECAST
• 22.6 PRODUCT
  • 22.6.1 MARKET SIZE & FORECAST
• 22.7 KEY COUNTRIES
• 22.8 TURKEY
  • 22.8.1 MARKET SIZE & FORECAST
• 22.9 SOUTH AFRICA
  • 22.9.1 MARKET SIZE & FORECAST
• 22.10 SAUDI ARABIA
  • 22.10.1 MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

• 23.1 COMPETITION OVERVIEW

24 KEY COMPANY PROFILES

• 24.1 COAST SCIENCE
  • 24.1.1 BUSINESS OVERVIEW
  • 24.1.2 PRODUCT OFFERINGS
  • 24.1.3 KEY STRATEGIES
  • 24.1.4 KEY STRENGTHS
  • 24.1.5 KEY OPPORTUNITIES
• 24.2 LENUS PHARMA GESMBH
  • 24.2.1 BUSINESS OVERVIEW
  • 24.2.2 PRODUCT OFFERINGS
  • 24.2.3 KEY STRATEGIES
  • 24.2.4 KEY STRENGTHS
  • 24.2.5 KEY OPPORTUNITIES
• 24.3 VITABIOTICS
  • 24.3.1 BUSINESS OVERVIEW
  • 24.3.2 PRODUCT OFFERINGS
  • 24.3.3 KEY STRATEGIES
  • 24.3.4 KEY STRENGTHS
  • 24.3.5 KEY OPPORTUNITIES
• 24.4 EXELTIS USA
  • 24.4.1 BUSINESS OVERVIEW
  • 24.4.2 PRODUCT OFFERINGS
  • 24.4.3 KEY STRATEGIES
  • 24.4.4 KEY STRENGTHS
  • 24.4.5 KEY OPPORTUNITIES
• 24.5 FAIRHAVEN HEALTH
  • 24.5.1 BUSINESS OVERVIEW
  • 24.5.2 PRODUCT OFFERINGS
  • 24.5.3 KEY STRATEGIES
  • 24.5.4 KEY STRENGTHS
  • 24.5.5 KEY OPPORTUNITIES
• 24.6 DABUR INDIA LTD.
  • 24.6.1 BUSINESS OVERVIEW
  • 24.6.2 PRODUCT OFFERINGS
  • 24.6.3 KEY STRATEGIES
  • 24.6.4 KEY STRENGTHS
  • 24.6.5 KEY OPPORTUNITIES
• 24.7 HERBALIFE INTERNATIONAL OF AMERICA, INC.
  • 24.7.1 BUSINESS OVERVIEW
  • 24.7.2 PRODUCT OFFERINGS
  • 24.7.3 KEY STRATEGIES
  • 24.7.4 KEY STRENGTHS
  • 24.7.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

• 25.1 ADVACARE PHARMA
  • 25.1.1 BUSINESS OVERVIEW
  • 25.1.2 PRODUCT OFFERINGS
• 25.2 BAYER AG
  • 25.2.1 BUSINESS OVERVIEW
  • 25.2.2 PRODUCT OFFERINGS
• 25.3 BELI
  • 25.3.1 BUSINESS OVERVIEW
  • 25.3.2 PRODUCT OFFERINGS
• 25.4 CADI - CAMBRIDGE DIAGNOSTIC IMAGING
  • 25.4.1 BUSINESS OVERVIEW
  • 25.4.2 PRODUCT OFFERINGS
• 25.5 CARLSON LABS
  • 25.5.1 BUSINESS OVERVIEW
  • 25.5.2 PRODUCT OFFERINGS
• 25.6 DCMG LABORATORIES
  • 25.6.1 BUSINESS OVERVIEW
  • 25.6.2 PRODUCT OFFERINGS
• 25.7 ELAN HEALTHCARE
  • 25.7.1 BUSINESS OVERVIEW
  • 25.7.2 PRODUCT OFFERINGS
• 25.8 EU NATURAL
  • 25.8.1 BUSINESS OVERVIEW
  • 25.8.2 PRODUCT OFFERINGS
• 25.9 FULLWELL
  • 25.9.1 BUSINESS OVERVIEW
  • 25.9.2 PRODUCT OFFERINGS
• 25.10 HERA (HERANOW)
  • 25.10.1 BUSINESS OVERVIEW
  • 25.10.2 PRODUCT OFFERINGS
• 25.11 INOVA PHARMACEUTICALS (PTY) LTD.
  • 25.11.1 BUSINESS OVERVIEW
  • 25.11.2 PRODUCT OFFERINGS
• 25.12 LABORATORIOS FERTYPHARM S.L.
  • 25.12.1 BUSINESS OVERVIEW
  • 25.12.2 PRODUCT OFFERINGS
• 25.13 LIFE EXTENSION
  • 25.13.1 BUSINESS OVERVIEW
  • 25.13.2 PRODUCT OFFERINGS
• 25.14 NUTRA BUSINESS
  • 25.14.1 BUSINESS OVERVIEW
  • 25.14.2 PRODUCT OFFERINGS
• 25.15 NUA FERTILITY
  • 25.15.1 BUSINESS OVERVIEW
  • 25.15.2 PRODUCT OFFERINGS
• 25.16 OCEAN HEALTHCARE
  • 25.16.1 BUSINESS OVERVIEW
  • 25.16.2 PRODUCT OFFERINGS
• 25.17 ORTHOMOL
  • 25.17.1 BUSINESS OVERVIEW
  • 25.17.2 PRODUCT OFFERINGS
• 25.18 PURITAN'S PRIDE
  • 25.18.1 BUSINESS OVERVIEW
  • 25.18.2 PRODUCT OFFERINGS
• 25.19 TTK
  • 25.19.1 BUSINESS OVERVIEW
  • 25.19.2 PRODUCT OFFERINGS
• 25.20 THORNE
  • 25.20.1 BUSINESS OVERVIEW
  • 25.20.2 PRODUCT OFFERINGS
• 25.21 AYTU CONSUMER HEALTH INC.
  • 25.21.1 BUSINESS OVERVIEW
  • 25.21.2 PRODUCT OFFERINGS
• 25.22 GNC HOLDINGS, LLC
  • 25.22.1 BUSINESS OVERVIEW
  • 25.22.2 PRODUCT OFFERINGS
• 25.23 HIMALAYA GLOBAL HOLDINGS LTD.
  • 25.23.1 BUSINESS OVERVIEW
  • 25.23.2 PRODUCT OFFERINGS
• 25.24 MAN MATTERS
  • 25.24.1 BUSINESS OVERVIEW
  • 25.24.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

• 26.1 KEY TAKEAWAYS
• 26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

• 27.1 MARKET BY GEOGRAPHY
• 27.2 MARKET BY GENDER
• 27.3 MARKET BY FORMULATION
• 27.4 MARKET BY DISTRIBUTION CHANNEL
• 27.5 MARKET BY PRODUCT
• 27.6 GENDER: MARKET BY GEOGRAPHY
  • 27.6.1 MEN: MARKET BY GEOGRAPHY
  • 27.6.2 WOMEN: MARKET BY GEOGRAPHY
• 27.7 FORMULATION: MARKET BY GEOGRAPHY
  • 27.7.1 CAPSULE: MARKET BY GEOGRAPHY
  • 27.7.2 TABLET: MARKET BY GEOGRAPHY
  • 27.7.3 SOFTGEL: MARKET BY GEOGRAPHY
  • 27.7.4 LIQUID: MARKET BY GEOGRAPHY
  • 27.7.5 POWDER: MARKET BY GEOGRAPHY
• 27.8 DISTRIBUTION CHANNEL: MARKET BY GEOGRAPHY
  • 27.8.1 OFFLINE STORE: MARKET BY GEOGRAPHY
  • 27.8.2 ONLINE STORE: MARKET BY GEOGRAPHY
• 27.9 PRODUCT: MARKET BY GEOGRAPHY
  • 27.9.1 NATURAL: MARKET BY GEOGRAPHY
  • 27.9.2 SYNTHETIC & BLEND: MARKET BY GEOGRAPHY

28 APPENDIX

• 28.1 ABBREVIATIONS